Tricia Mulford

Tricia Mulford currently serves as Executive Director at Heron Therapeutics, Inc., building on a robust background in pharmacovigilance and drug safety. Previously held positions at Ardea Biosciences included Senior Manager and Director of Pharmacovigilance, where responsibilities encompassed leading teams, ensuring regulatory compliance, managing budgets, and overseeing safety databases. Additional experiences include consulting in pharmacovigilance, training and drug safety coordination at Orexigen Therapeutics, and drug safety roles at Valeant Pharmaceuticals. Tricia Mulford began medical career as a clinical nurse specialist in a surgical trauma ICU and holds a Bachelor's in Health Administration from California State University, Northridge, along with certifications in Biomedical Quality Systems and Registered Nursing.